Bioassay Services Market is Segmented By Type of Therapy (Cell Therapy, Gene Therapy), By Therapeutic Area (Oncological Disorders, Infectious Diseases....
Market Size in USD
CAGR30.1%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 30.1% |
Market Concentration | High |
Major Players | CCRM, Nexelis, Pacific BioLabs, PPD Laboratories, WuXi Advanced Therapies |
The bioassay services market is estimated to be valued at USD 340 Mn in 2024 and is expected to reach USD 2,160 Mn by 2031, growing at a compound annual growth rate (CAGR) of 30.1% from 2024 to 2031.
The market for bioassay services has been witnessing strong growth over the past few years. Continuous technological advancements in the field of drug discovery along with growing research activities in the pharmaceutical industry have been the major factors influencing the demand for various bioassay services. Moreover, rising outsourcing of non-core research activities by biotechnology and pharmaceutical companies is expected to drive increased reliance on specialized bioassay laboratories.